<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font28">the </span>
   <span class="font19">(.%) </span>
   <span class="font17">were </span>
   <span class="font17">(.–.) </span>
   <span class="font17">for </span>
   <span class="font15">fenofibrate </span>
   <span class="font15">aortic </span>
   <span class="font15">patients </span>
   <span class="font14">was </span>
   <span class="font14">AAA </span>
   <span class="font14">concentrations </span>
   <span class="font14">with </span>
   <span class="font13">between </span>
   <span class="font13">that </span>
   <span class="font13">abdominal </span>
   <span class="font13">;:–. </span>
   <span class="font13">The </span>
   <span class="font13">trial </span>
   <span class="font13">{background </span>
   <span class="font12">allocated </span>
   <span class="font12">groups </span>
   <span class="font12">margin </span>
   <span class="font12">study </span>
   <span class="font12">circulating </span>
   <span class="font12">data </span>
   <span class="font12">this </span>
   <span class="font12">{border-style </span>
   <span class="font12">from </span>
   <span class="font12">not </span>
   <span class="font12">using </span>
   <span class="font11">px;} </span>
   <span class="font11">serum </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">placebo </span>
   <span class="font11">time </span>
   <span class="font11">Fenofibrate </span>
   <span class="font11">had </span>
   <span class="font11">aneurysm </span>
   <span class="font11">assessed </span>
   <span class="font11">randomized </span>
   <span class="font11">treatment </span>
   <span class="font11">osteopontin </span>
   <span class="font11">GolledgeJ. </span>
   <span class="font11">Table </span>
   <span class="font11">are </span>
   <span class="font11">effects </span>
   <span class="font11">lipoprotein </span>
   <span class="font11">growth </span>
   <span class="font11">small </span>
   <span class="font11">these </span>
   <span class="font11">weeks </span>
   <span class="font11">Research </span>
   <span class="font11">current </span>
   <span class="font11">differences </span>
   <span class="font11">have </span>
   <span class="font11">low‐density </span>
   <span class="font11">participants </span>
   <span class="font11">total </span>
   <span class="font10">AAAs </span>
   <span class="font10">All </span>
   <span class="font10">MoxonJV, </span>
   <span class="font10">Serum </span>
   <span class="font10">allocation </span>
   <span class="font10">drug </span>
   <span class="font10">each </span>
   <span class="font10">group </span>
   <span class="font10">kallistatin </span>
   <span class="font10">observed </span>
   <span class="font10">significant </span>
   <span class="font10">trial. </span>
   <span class="font10">wall </span>
   <span class="font10">Heart </span>
   <span class="font10">Surg. </span>
   <span class="font10">Vascular </span>
   <span class="font10">aneurysms. </span>
   <span class="font10">cholesterol </span>
   <span class="font10">compared </span>
   <span class="font10">did </span>
   <span class="font10">outcome </span>
   <span class="font10">px; </span>
   <span class="font10">suggested </span>
   <span class="font10">{font-family </span>
   <span class="font10">(Figure </span>
   <span class="font10">(n=) </span>
   <span class="font10">Aneurysm </span>
   <span class="font10">Circulating </span>
   <span class="font10">Clinical </span>
   <span class="font10">Figure </span>
   <span class="font10">GolledgeJ, </span>
   <span class="font10">Group </span>
   <span class="font10">Health </span>
   <span class="font10">This </span>
   <span class="font10">Trial </span>
   <span class="font10">after </span>
   <span class="font10">all </span>
   <span class="font10">aneurysm. </span>
   <span class="font10">biomarkers </span>
   <span class="font10">difference </span>
   <span class="font10">follow‐up </span>
   <span class="font10">font-size </span>
   <span class="font10">included </span>
   <span class="font10">interaction </span>
   <span class="font10">linear </span>
   <span class="font10">may </span>
   <span class="font10">measuring </span>
   <span class="font10">osteoprotegerin </span>
   <span class="font10">other </span>
   <span class="font10">per </span>
   <span class="font10">primary </span>
   <span class="font10">rate </span>
   <span class="font10">repair </span>
   <span class="font10">therapy </span>
   <span class="font10">triglyceride </span>
   <span class="font10">Abdominal </span>
   <span class="font10">Management </span>
   <span class="font10">Queensland </span>
   <span class="font10">S). </span>
   <span class="font10">administration </span>
   <span class="font10">analysis. </span>
   <span class="font10">baseline </span>
   <span class="font10">clinical </span>
   <span class="font10">considered </span>
   <span class="font10">diameter </span>
   <span class="font10">double; </span>
   <span class="font10">effect </span>
   <span class="font10">events </span>
   <span class="font10">mixed </span>
   <span class="font10">pathology </span>
   <span class="font10">previously </span>
   <span class="font10">reduce </span>
   <span class="font10">reductions </span>
   <span class="font10">size </span>
   <span class="font10">value </span>
   <span class="font10">weeks. </span>
   <span class="font10">which </span>
   <span class="font10">within </span>
   <span class="font10">would </span>
   <span class="font10">;:. </span>
   <span class="font10">Aortic </span>
   <span class="font10">Eur </span>
   <span class="font10">FAME‐ </span>
   <span class="font10">For </span>
   <span class="font10">LME </span>
   <span class="font10">NormanPE. </span>
   <span class="font10">Other </span>
   <span class="font10">Vasc </span>
   <span class="font10">adverse </span>
   <span class="font10">also </span>
   <span class="font10">although </span>
   <span class="font10">analyses </span>
   <span class="font10">artery </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">collab: </span>
   <span class="font10">concentration </span>
   <span class="font10">currently </span>
   <span class="font10">disease. </span>
   <span class="font10">drugs </span>
   <span class="font10">edge </span>
   <span class="font10">expected </span>
   <span class="font10">findings </span>
   <span class="font10">groups. </span>
   <span class="font10">high‐density </span>
   <span class="font10">leading </span>
   <span class="font10">likely </span>
   <span class="font10">management </span>
   <span class="font10">markers </span>
   <span class="font10">matrix </span>
   <span class="font10">measured </span>
   <span class="font10">mmol/L </span>
   <span class="font10">number </span>
   <span class="font10">over </span>
   <span class="font10">placebo‐controlled </span>
   <span class="font10">plasma </span>
   <span class="font10">prescribed </span>
   <span class="font10">previous </span>
   <span class="font10">protocol </span>
   <span class="font10">recruitment </span>
   <span class="font10">refers </span>
   <span class="font10">risk </span>
   <span class="font10">samples </span>
   <span class="font10">significantly </span>
   <span class="font10">solid; </span>
   <span class="font10">surveillance </span>
   <span class="font10">through </span>
   <span class="font10">unadjusted </span>
   <span class="font10">very </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(blue </span>
   <span class="font10">(observer </span>
   <span class="font10">(red </span>
   <span class="font10">Atherosclerosis. </span>
   <span class="font10">Australian </span>
   <span class="font10">Baseline </span>
   <span class="font10">CHD </span>
   <span class="font10">Characteristics </span>
   <span class="font10">ClancyP, </span>
   <span class="font10">D‐dimer, </span>
   <span class="font10">MMP‐, </span>
   <span class="font10">Medical </span>
   <span class="font10">National </span>
   <span class="font10">NormanPE, </span>
   <span class="font10">Participants </span>
   <span class="font10">Patients </span>
   <span class="font10">analysis </span>
   <span class="font10">anticipated </span>
   <span class="font10">aorta </span>
   <span class="font10">assess </span>
   <span class="font10">associated </span>
   <span class="font10">based </span>
   <span class="font10">been </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">changes </span>
   <span class="font10">circles) </span>
   <span class="font10">collected </span>
   <span class="font10">comparison </span>
   <span class="font10">controlled </span>
   <span class="font10">coronary </span>
   <span class="font10">courier; </span>
   <span class="font10">day </span>
   <span class="font10">demonstrated </span>
   <span class="font10">determined </span>
   <span class="font10">diagnosis </span>
   <span class="font10">during </span>
   <span class="font10">em; </span>
   <span class="font10">estimated </span>
   <span class="font10">filtration </span>
   <span class="font10">glomerular </span>
   <span class="font10">guidelines </span>
   <span class="font10">has </span>
   <span class="font10">inner </span>
   <span class="font10">mass </span>
   <span class="font10">measurements </span>
   <span class="font10">measures </span>
   <span class="font10">medication </span>
   <span class="font10">men </span>
   <span class="font10">model </span>
   <span class="font10">ng/mL </span>
   <span class="font10">outer </span>
   <span class="font10">point </span>
   <span class="font10">potential </span>
   <span class="font10">presented </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomised </span>
   <span class="font10">receive </span>
   <span class="font10">receiving </span>
   <span class="font10">reduction </span>
   <span class="font10">reported </span>
   <span class="font10">resistin, </span>
   <span class="font10">sample </span>
   <span class="font10">several </span>
   <span class="font10">site </span>
   <span class="font10">squares) </span>
   <span class="font10">studies </span>
   <span class="font10">study. </span>
   <span class="font10">test </span>
   <span class="font10">they </span>
   <span class="font10">trial, </span>
   <span class="font10">used </span>
   <span class="font10">values </span>
   <span class="font10">variables </span>
  </p>
 </body>
</html>
